LCTX

Lineage Cell Therapeutics Inc

$1.96

+0.06 (+3.16%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$4.17
(+112.6%)
Strong Buy: 1
Buy: 5
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
2173 SALK AVENUE, CARLSBAD, CA, UNITED STATES, 92008
Fiscal year end:
December
Market capitalization:
$438 Million
EBITDA:
-$19.7 Million
PERatio:
0.0
EPS:
-0.29
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.801

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-30%
How much will you get:
$699
Prices dates:
29-01-2016: $2.12 and 30-01-2026: $1.48